RESIL® Certified for Expanded Biostimulant Efficacy Claims in the EU
Initially certified in 2023, RESIL® was one of the first plant biostimulant products recognized as a non-microbial biostimulant (PFC 6.B) in accordance with the new and stringent EU regulations. The certification of this industry-leading biostimulant was backed by a comprehensive dossier of efficacy data supporting its ability to increase crop yields across all broadacre crops and enhance tolerance to abiotic stress in Brassica napus L (canola). With the latest certification update, the product's performance claims have been officially broadened, offering even greater agronomic and commercial value to growers across the EU. The expanded certification specifically covers the following claims:
Strengthening drought and heat stress tolerance for all 42 crops identified in the broadacre crop grouping and all 83 crops in the vegetables, ornamental and AMP crops grouping outlined in the EN 17700:1 standard.
Improving nutrient use efficiency for all three essential nutrients - nitrogen, phosphorus, and potassium – across all crops in the broadacre grouping.
Significantly enhancing multiple quality traits, including increasing the number of pods per plant, plant weight, root growth, the number of seeds per plant and the overall yield for all crops in the broadacre grouping.
Increasing several quality traits in vegetable, ornamental, and AMP crops – most notably chlorophyll content, marketable fruit yield, fruit and plant weight, root growth and overall yield.
Plant biostimulants improve nutrient availability, uptake, or use efficiency, and tolerance to abiotic stress. They often have similar modes of action across all crops and enhance crop growth, development, quality and/or yield. The CE mark ensures growers that the biostimulants they are using are quality products, effective, and safe for the environment.
"This expanded certification highlights RESIL®'s versatility, efficacy, and safety, positioning it as the essential solution for European growers to improve crop resilience and manage the unknown" said Gieljam Dejong of NutriTrain. "We see strong demand, particularly in vegetable and AMP sectors, for biostimulants that tangibly improve sustainability and efficiency."
RESIL®, also known as BioLiNE® Gold, has been commercially marketed to growers in North America since 2018. The technology has a proven track record of effectiveness on over one million hectares of crops annually across Canada and the U.S. In, 2024, BioLiNE® Gold, became one of the first biostimulant products to achieve certification under the Certified Biostimulant program, administered by The Fertilizer Institute.
The Go-To Tool in Every Grower's Toolbox
RESIL® is a simple, effective, and affordable go-to-tool for helping growers manage their crops. Supplementing crop production with RESIL® helps growers improve yields, maximize inputs, and sustain healthy soils. This effective biostimulant is helping growers improve margins and manage the risk posed to their crops by environmental stress factors such as heat and drought. The technology is essential to supporting crops' natural defenses, and contributing to crop vitality, stress resistance and yield optimization. The versatility of RESIL® keeps things simple for farmers and fertilizing product formulators. RESIL® can be mixed or added to almost all agricultural inputs and can be applied with all common nutrient and/or pesticide sprays.
For more information in North America, please contact Mohammad Rahbari, EVP Innovation & Sustainability, mrahbari@biolinecorp.ca, 519-495-9808, www.biolinecorp.ca
For more information in Europe, please contact Gieljam Dejong, Chief Growth Officer, 0031622870504, gieljam@nutritrain.eu
Media Contact:Mohammad RahbariEVP Innovation & Sustainability for Bioline Corp.519-495-9808396777@email4pr.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/resil-certified-for-expanded-biostimulant-efficacy-claims-in-the-eu-302483649.html
SOURCE BioLiNE Corporation
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Post
28 minutes ago
- New York Post
How drugs like Ozempic can help treat asthma — even if you don't have diabetes
Asthma sufferers, get pumped! Managing asthma often requires a two-pronged approach — long-term medicines to prevent attacks and rescue strategies to stop attacks when they happen. It's important to avoid triggers and monitor breathing. New research out of the UK suggests that GLP-1 medications like Ozempic and Victoza may provide long-term asthma relief — in addition to shrinking waistlines. Advertisement 4 Asthma sufferers may benefit from GLP-1 drugs like Ozempic and Wegovy, a new study finds. Pixel-Shot – 'This study is a good reminder that GLP-1s shouldn't just be labeled as 'weight loss drugs,'' Dr. Michael Snyder, who was not involved in the new study, told The Post. 'They're part of a broader shift in medicine toward treating chronic diseases at the systems level.' Advertisement Researchers from the University of Aberdeen and the Observational and Pragmatic Research Institute studied over 10,000 obese, asthmatic patients taking GLP-1 drugs, comparing them to about 50,000 adults who had similar medical histories but were not taking GLP-1s. The GLP-1 users had fewer asthma attacks and symptoms after a year, though there wasn't much difference between that group and the asthma patients not on GLP-1 drugs. 4 GLP-1s often cause weight loss, which has been shown to reduce the severity of asthma. Other factors may also be at play. millaf – The researchers attributed this outcome to 'large numbers of missing data' due to disruptions in information collection during the COVID-19 pandemic. Advertisement Though the data was limited, the study authors noted that the GLP-1 group shed an average of 7.7 pounds while the other group lost an average of 2 pounds. It's unclear if the GLP-1 participants suffered side effects like nausea or vomiting. The results were published recently in the journal Advances in Therapy. This is not the first study to demonstrate that GLP-1 drugs can help asthma sufferers, particularly those with Type 2 diabetes and obesity. Advertisement Obesity is a well-known risk factor for asthma. One reason is that fat tissue can produce inflammatory substances that negatively affect the lungs and worsen asthma. GLP-1 drugs often cause weight loss because they mimic the GLP-1 hormone the body naturally produces after eating. Appetite decreases as users feel fuller for longer. The meds are prescribed to people with obesity and/or Type 2 diabetes. 4 Managing asthma often requires a two-pronged approach — long-term medicines to prevent attacks and rescue strategies to stop attacks when they happen. Pixel-Shot – Snyder, medical director of the Bariatric Surgery Center at Rose Medical Center in Denver and in-house obesity specialist at FuturHealth, suggests that these drugs could be useful for asthmatics who aren't obese or diabetic. 'These drugs appear to have anti-inflammatory effects, which is key since asthma is, at its core, an inflammatory disease,' Snyder said. 'They may also help calm airway hyperresponsiveness — in other words, making the lungs less reactive to common asthma triggers like allergens or pollution,' he added. 'And of course, the weight loss many patients experience can also improve lung function and reduce asthma severity, so it's likely a combination of these effects working together.' Snyder said more research is needed to confirm the effects in people who are not obese. Advertisement Dr. Thomas Kilkenny, director of the Institute of Sleep Medicine, Pulmonary & Critical Care at Northwell's Staten Island University Hospital, said the participants' better breathing is simply due to the weight loss. 'It has been shown multiple times in the past, and various studies show that weight loss alone improves asthma control,' Kilkenny told MedicalNewsToday. 4 Researchers have long been exploring uses for GLP-1 drugs beyond obesity and Type 2 diabetes. Fernanda – 'This study did not comment on whether the GLP-1 medication had a direct effect on the physiology of asthma control,' he added. Advertisement Since the first GLP-1 drug was approved 20 years ago to treat Type 2 diabetes, researchers have suggested that these meds can also relieve knee osteoarthritis pain, calm skin conditions, lower the odds of heart troubles and reduce dementia risk. 'Conditions like asthma, diabetes, sleep apnea, dementia and even cardiovascular disease don't exist in silos; they're deeply interconnected,' Snyder said. 'The fact that GLP-1s may impact all of them suggests we're entering a new era where the focus is not just on symptom management, but on rebalancing the underlying biology driving disease.'
Yahoo
37 minutes ago
- Yahoo
Best CD rates today, July 31, 2025 (lock in up to 5.5% APY)
Find out which banks are offering the best CD rates right now. If you're looking for a secure place to store your savings, a certificate of deposit (CD) may be a great choice. These accounts often provide higher interest rates than traditional checking and savings accounts. However, CD rates can vary widely. Learn more about where CD rates stand today and how to find the best rates available. Banks with the best CD rates today CD rates are relatively high compared to historical averages. That said, CD rates have been on the decline since last year when the Federal Reserve began cutting its target rate. The good news is that several financial institutions offer competitive rates of 4% APY and up, particularly online banks. As of July 31, 2025, the highest CD rate is 5.5% APY, offered by Gainbridge® on its 5-year CD. There is a $1000 minimum opening deposit required. Here is a look at some of the best CD rates available today from our verified partners: CD rate predictions for 2025 The Federal Reserve recently began decreasing the federal funds rate in light of slowing inflation and an overall improved economic outlook. It cut its target rate three times in late 2024 by a total of one percentage point. The Fed has indicated it will continue cutting its target rate in 2025. However, it now projects a total of two cuts, down from its previous projection of four. The federal funds rate doesn't directly impact deposit interest rates, though they are correlated. When the Fed lowers rates, financial institutions typically follow suit (and vice versa). So now that the Fed has lowered its rate, CD rates are beginning to fall again. That's why now may be a good time to put your money in a CD and lock in today's best rates. How to open a CD The process for opening a CD account varies by financial institution. However, there are a few general steps you can expect to follow: Research CD rates: One of the most important factors to consider when opening a CD is whether the account provides a competitive rate. You can easily compare CD rates online to find the best offers. Choose an account that meets your needs: While a CD's interest rate is a key consideration, it shouldn't be the only one. You should also evaluate the CD's term length, minimum opening deposit requirements, and fees to ensure a particular account fits your financial needs and goals. For example, you want to avoid choosing a CD term that's too long, otherwise you'll be subject to an early withdrawal penalty if you need to pull out your funds before the CD matures. Get your documents ready: When opening a bank account, you will need to provide a few pieces of information, including your Social Security number, address, and driver's license or passport number. Having these documents on hand will help streamline the application process. Complete the application: These days, many financial institutions allow you to apply for an account online, though you might have to visit the branch in some cases. Either way, the application for a new CD should only take a few minutes to complete. And in many cases, you'll get your approval decision instantly. Fund the account: Once your CD application is approved, it's time to fund the account. This can usually be done by transferring money from another account or mailing a check. Read more: Step-by-step instructions for opening a CD
Yahoo
an hour ago
- Yahoo
Cool Off This August with Root Beer Ice Cream at Cold Stone Creamery®
SCOTTSDALE, Ariz., Aug. 1, 2025 /PRNewswire/ -- Cold Stone Creamery® ( is bringing nostalgic flavors to the forefront this summer with the launch of its limited-time Root Beer Ice Cream, available now through August 31. Inspired by the classic soda fountain favorite, this flavor offers a refreshing and creamy twist on a beloved American tradition. Root Beer Ice Cream is handcrafted fresh in every store and can be enjoyed on its own or as part of two delicious offerings. The Root Beer Revival Creation™ mixes Root Beer Ice Cream with chocolate chips, caramel, and whipped topping, while the Go With the Float, our take on the classic soda shop root beer float, features Root Beer Ice Cream and root beer topped with whipped topping and a maraschino cherry. "Root Beer Ice Cream is a nostalgic flavor that instantly takes you back in time," said Courtney Maxedon VP of Marketing and Digital Strategy at Kahala Brands™, parent company of Cold Stone Creamery. "We wanted to capture that classic root beer float experience and serve it up in a way that only Cold Stone can - bold, creamy, and full of flavor." Don't miss your chance to experience this limited-time flavor. Whether you're reliving childhood memories or discovering root beer in a whole new way, our Root Beer Ice Cream is the perfect way to cool off your August. Available in stores and online, this ice cream won't be around for long, so grab it while you can! Promotional Flavor: Root Beer Ice Cream Promotional Creation™: Root Beer Revival - Root Beer Ice Cream, Chocolate Chips, Caramel & Whipped Topping Promotional Float: Go With the Float - Root Beer Ice Cream, Root Beer, Whipped Topping & a Maraschino Cherry About Cold Stone CreameryCold Stone Creamery® delivers the Ultimate Ice Cream Experience® through a community of franchisees who are passionate about ice cream. The secret recipe for smooth and creamy ice cream is handcrafted fresh daily in each store, and then customized by combining a variety of mix-ins on a frozen granite stone. Headquartered in Scottsdale, Arizona, Cold Stone Creamery is owned by parent company Kahala Brands™, one of the fastest growing franchising companies in the world with a portfolio of nearly 30 fast-casual and quick-service restaurant brands with approximately 3,000 locations in 35 countries. The Cold Stone Creamery brand operates nearly 1,500 locations globally in approximately 30 countries worldwide. For more information about Cold Stone Creamery, visit View original content to download multimedia: SOURCE Cold Stone Creamery Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
